Multiple sclerosis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 7: Line 7:
== Epidemiology and Demographics==
== Epidemiology and Demographics==


There is a lower frequency of people suffering from Multiple Sclerosis among citizens of the Arabian Peninsula, Asia, and continental South America than people living in northern Europe, continental North America, and Australasia, which is about one of every 1000 citizens. In addition, in sub-Saharan Africa, [[MS]] is extremely rare.<ref>[http://www.fedem.org/revista/n16/kurtzkeing.htm Epidemiology and multiple sclerosis. a personal review]</ref> Several factors such as climate, diet, geomagnetism, toxins, sunlight exposure, genetic factors, and infectious have been proved to cause these regional differences. Also, Factors such as Childhood environmental factors may play an important role in progress of [[MS]] later in life. Various studies on migrants support this idea by stating that immigration occurs before the age of fifteen, the migrant acquires the new region's susceptibility to [[MS]]. But, if migration takes place after age fifteen, the migrant keeps the susceptibility of his home country.<ref>Marrie, RA. ''Environmental risk factors in multiple sclerosis aetiology.'' Lancet Neurol. 2004 Dec;3(12):709-18. Review. PMID 15556803</ref> However, other studies suggest larger timescale than the first 15 years of life for the growth of [[MS]] age/geographical risks.<ref name="pmid10775541">{{cite journal |author=Hammond SR, English DR, McLeod JG |title=The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia |journal=Brain |volume=123 ( Pt 5) |issue= |pages=968–74 |year=2000 |pmid=10775541 |doi=}}</ref>
There is a lower frequency of people suffering from Multiple Sclerosis among citizens of the Arabian Peninsula, Asia, and continental South America than people living in northern Europe, continental North America, and Australasia, which is about one of every 1000 citizens. In addition, in sub-Saharan Africa, [[MS]] is extremely rare.<ref>[http://www.fedem.org/revista/n16/kurtzkeing.htm Epidemiology and multiple sclerosis. a personal review]</ref> factors including sunlight exposure, climate, [[diet]], [[toxins]], [[genetic]] factors, geomagnetism, Childhood environmental factors and [[infections]] have been proved to cause this differences in [[MS]] prevalence. Several studies demonstrated that if immigration occurs before the age of fifteen, the migrant's susceptibility to [[MS]] will be equal to that region's native people, But if migration occurs after the age of fifteen, the migrant's susceptibility will remain equal to his home country.<ref>Marrie, RA. ''Environmental risk factors in multiple sclerosis aetiology.'' Lancet Neurol. 2004 Dec;3(12):709-18. Review. PMID 15556803</ref>  


The occurrence of [[MS]] varies among countries for an unknown reason. Based on different studies, it has been proved that [[MS]] occurs mainly in Caucasians while in the Native American tribes of North America, Australian Aborigines and the Māori of New Zealand, [[MS]] is very rare. Also, among Canadians living in the same region, Inuit people have a twenty fold lower occurrence. Scotland appears to have the highest rate of [[MS]] in the world.<ref>{{cite journal |author=Rothwell PM, Charlton D |title=High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition |journal=J. Neurol. Neurosurg. Psychiatr. |volume=64 |issue=6 |pages=730-5 |year=1998 |pmid=9647300 |doi=}}</ref> Therefore, it is supposed that probably due to either [[genetic]] background or [[lifestyle]] and cultural factors, the development of this [[disease]] is not equal in various regions. Moreover, as observed in many [[autoimmune disorders]], [[MS]] is at least two times more common among women than men. However, males and females over age fifty, may have an equal ratio.This ratio among children may reach three females for each male. Onset of [[symptoms]] is mostly between age of fifteen to forty years, rarely before age fifteen or after age sixty. As previously discussed, [[Genetics|genetic]] factors are an important component to [[MS]]. It is estimated that on average, one of every siblings of individuals with [[MS]] may develop this [[disease]] as well. Among [[identical twins]] of [[MS]]-affected individuals, almost half of them will develop [[MS]], but only one of twenty [[fraternal twins]]. In addition, if one of the parents is affected by [[MS]], the risk of developing [[MS]] for each child is about one in forty.<ref>Sadovnick, AD, Ebers, GC, Dyment, DA, Risch, NJ. ''Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group.'' Lancet 1996; 347:1728. PMID 8656905</ref>
The prevalence of [[MS]] varies among countries. according to some studies [[MS]] occurs mostly in Caucasians while it is rare in the Native American tribes of North America, Australian Aborigines and the Māori of New Zealand. Among countries Scotland seems to have the highest rate of [[MS]] in the world.<ref>{{cite journal |author=Rothwell PM, Charlton D |title=High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition |journal=J. Neurol. Neurosurg. Psychiatr. |volume=64 |issue=6 |pages=730-5 |year=1998 |pmid=9647300 |doi=}}</ref> We can conclude that due to [[genetic]] susceptibility, [[lifestyle]] and different culture, the development of this [[disease]] is not equal in various regions. [[autoimmune disorders]] such as [[MS]] is at least two times more common among women than men but this difference will disappear after the age of 50 and in children reach three females for each male. Onset of [[symptoms]] is mostly between age of fifteen to forty years, rarely before age fifteen or after age sixty. [[Genetics|genetic]] factors are an important risk factors to [[MS]] disease. It is estimated that among [[MS]] patients siblings, one can be affected eventually. The [[Identical twin|identical twins]] of [[MS]]-affected individuals, almost half of them will develop [[MS]], but in [[fraternal twins]] it's one of twenty.if one of the parents is affected by [[MS]], the risk of developing [[MS]] for each child is about one in forty.<ref>Sadovnick, AD, Ebers, GC, Dyment, DA, Risch, NJ. ''Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group.'' Lancet 1996; 347:1728. PMID 8656905</ref>


In the end, it is important to highlight that some studies on related [[diseases]] have shown that some formerly considered [[MS]] cases are not [[MS]] at all. In fact, all the studies before 2004 can be affected by the impossibility to distinguish [[MS]] and [[Devic's disease]] (NMO) reliably before this date.<ref>{{cite journal |author=Weinshenker B |title=Western vs optic-spinal MS: two diseases, one treatment?|journal=Neurology |volume=64 |issue=4 |pages=594-5 |year=2005 |pmid=15728277}}</ref>
it is important to say that some studies on related [[diseases]] have shown that some diseases which were formerly considered [[MS]] cases are not [[MS]] at all. all the studies before 2004 can be affected because of inability to distinguish [[MS]] and [[Devic's disease]] (NMO).<ref>{{cite journal |author=Weinshenker B |title=Western vs optic-spinal MS: two diseases, one treatment?|journal=Neurology |volume=64 |issue=4 |pages=594-5 |year=2005 |pmid=15728277}}</ref>
<gallery>
<gallery>



Revision as of 20:28, 6 March 2018

Multiple sclerosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple sclerosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Alternative Therapies

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Multiple sclerosis epidemiology and demographics On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple sclerosis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple sclerosis epidemiology and demographics

CDC on Multiple sclerosis epidemiology and demographics

Multiple sclerosis epidemiology and demographics in the news

Blogs on Multiple sclerosis epidemiology and demographics

Directions to Hospitals Treating Multiple sclerosis

Risk calculators and risk factors for Multiple sclerosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Epidemiology and Demographics

There is a lower frequency of people suffering from Multiple Sclerosis among citizens of the Arabian Peninsula, Asia, and continental South America than people living in northern Europe, continental North America, and Australasia, which is about one of every 1000 citizens. In addition, in sub-Saharan Africa, MS is extremely rare.[1] factors including sunlight exposure, climate, diet, toxins, genetic factors, geomagnetism, Childhood environmental factors and infections have been proved to cause this differences in MS prevalence. Several studies demonstrated that if immigration occurs before the age of fifteen, the migrant's susceptibility to MS will be equal to that region's native people, But if migration occurs after the age of fifteen, the migrant's susceptibility will remain equal to his home country.[2]

The prevalence of MS varies among countries. according to some studies MS occurs mostly in Caucasians while it is rare in the Native American tribes of North America, Australian Aborigines and the Māori of New Zealand. Among countries Scotland seems to have the highest rate of MS in the world.[3] We can conclude that due to genetic susceptibility, lifestyle and different culture, the development of this disease is not equal in various regions. autoimmune disorders such as MS is at least two times more common among women than men but this difference will disappear after the age of 50 and in children reach three females for each male. Onset of symptoms is mostly between age of fifteen to forty years, rarely before age fifteen or after age sixty. genetic factors are an important risk factors to MS disease. It is estimated that among MS patients siblings, one can be affected eventually. The identical twins of MS-affected individuals, almost half of them will develop MS, but in fraternal twins it's one of twenty.if one of the parents is affected by MS, the risk of developing MS for each child is about one in forty.[4]

it is important to say that some studies on related diseases have shown that some diseases which were formerly considered MS cases are not MS at all. all the studies before 2004 can be affected because of inability to distinguish MS and Devic's disease (NMO).[5]

References

  1. Epidemiology and multiple sclerosis. a personal review
  2. Marrie, RA. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol. 2004 Dec;3(12):709-18. Review. PMID 15556803
  3. Rothwell PM, Charlton D (1998). "High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition". J. Neurol. Neurosurg. Psychiatr. 64 (6): 730–5. PMID 9647300.
  4. Sadovnick, AD, Ebers, GC, Dyment, DA, Risch, NJ. Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet 1996; 347:1728. PMID 8656905
  5. Weinshenker B (2005). "Western vs optic-spinal MS: two diseases, one treatment?". Neurology. 64 (4): 594–5. PMID 15728277.

Template:WH Template:WS